Key stats
About First Trust Amex Biotech Index Fund
Home page
Inception date
Jun 19, 2006
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Distribution tax treatment
Qualified dividends
Income tax type
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Primary advisor
First Trust Advisors LP
Distributor
First Trust Portfolios LP
FBT provides exposure to biotech companies involved in the use of biological processes to develop products or provide services. The underlying index contains 30 names, an increase from 20 in October 2014. Without a specific sector classification scheme, the funds broad exposure could include access to pharmaceuticals and medical technology in addition to traditional biotech. Still, FBTs equal weighting of about 30 stocks produces a relatively concentrated basket. The index is reconstituted and rebalanced quarterly.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks99.94%
Health Technology99.94%
Bonds, Cash & Other0.06%
Cash0.06%
Stock breakdown by region
North America82.83%
Europe17.17%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
FBT top holdings are ACADIA Pharmaceuticals Inc. and Neurocrine Biosciences, Inc., occupying 4.62% and 4.23% of the portfolio correspondingly.
FBT assets under management is 1.02 B USD. It's risen 1.28% over the last month.
FBT fund flows account for −186.20 M USD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Yes, FBT pays dividends to its holders with the dividend yield of 0.71%. The last dividend (Dec 31, 2024) amounted to 1.17 USD. The dividends are paid quarterly.
FBT shares are issued by AJM Ventures LLC under the brand First Trust. The ETF was launched on Jun 19, 2006, and its management style is Passive.
FBT expense ratio is 0.54% meaning you'd have to pay 0.54% of your investment to help manage the fund.
FBT follows the NYSE Arca Biotechnology Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
FBT invests in stocks.
FBT price has risen by 5.36% over the last month, and its yearly performance shows a 7.11% increase. See more dynamics on FBT price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 0.31% over the last month, showed a −5.14% decrease in three-month performance and has increased by 7.92% in a year.
NAV returns, another gauge of an ETF dynamics, have risen by 0.31% over the last month, showed a −5.14% decrease in three-month performance and has increased by 7.92% in a year.
FBT trades at a premium (0.14%) meaning the ETF is trading at a higher price than the calculated NAV.